Data integrity – Page 18

How to Prevent Hybrid LIMS Worksheets in Hybrid Paper–Electronic Systems

Effective Strategies to Manage Hybrid LIMS Worksheets in Hybrid Paper–Electronic Systems In today’s pharmaceutical landscape, the integration of hybrid paper–electronic systems (LIMS) presents unique challenges, notably related to data integrity…

How to Prepare GDP Records for FDA and MHRA Inspection

Essential Strategies for GDP Record Preparation for FDA and MHRA Audits In the highly regulated pharmaceutical environment, meeting Good Documentation Practices (GDP) is crucial for successful inspections by bodies such…

Step-by-Step Guide to Managing Controlled Notebook Governance Under ALCOA+ Expectations

Effectively Managing Controlled Notebook Governance in Compliance with ALCOA+ Standards In the pharmaceutical industry, maintaining data integrity throughout the drug manufacturing process is paramount. The integration of hybrid paper-electronic systems…

Good Documentation Practices for Sampling and Chain of Custody

Case Study: Enhancing Good Documentation Practices in Sampling and Chain of Custody In a pharmaceutical facility, the integrity of data is paramount to maintaining compliance with regulations. This case study…

Why Paper Form Version Control Happens and How QA Teams Should Control It

Understanding and Controlling Version Issues in Hybrid Paper-Electronic GMP Records In the ever-evolving landscape of pharmaceutical manufacturing, the integration of hybrid paper-electronic systems has become a necessity. However, issues related…

GDP for QC Laboratories: Raw Data, Worksheets, and Review

Addressing GDP Compliance Issues in QC Laboratories: A Practical Guide In the regulated environment of pharmaceutical manufacturing, good documentation practices (GDP) are essential for ensuring data integrity, compliance, and quality…

Inspection-Ready Approach to Unique Record Identifier Design in Pharmaceutical Operations

Effective Strategies for Designing Unique Record Identifiers in Hybrid Paper–Electronic Pharmaceutical Operations In today’s pharmaceutical landscape, ensuring data integrity within hybrid paper-electronic systems is essential for regulatory compliance and operational…

How to Document Corrections Without Obscuring Original Entries

Effective Strategies for Documenting Corrections While Preserving Original Entries In the pharmaceutical industry, proper documentation is critical to maintaining compliance with regulations and ensuring data integrity. When errors occur in…

Hybrid Record Inspection Readiness: Root Causes, GMP Risks, and CAPA Controls

Ensuring Inspection Readiness for Hybrid Record Systems: Addressing Root Causes and GMP Risks In the world of pharmaceutical manufacturing, hybrid paper-electronic systems have become popular for their flexibility and efficiency.…

ALCOA+ and Hybrid Paper Electronic Documentation Risks

Mitigating Risks Associated with ALCOA+ and Hybrid Paper Electronic Documentation In the ever-evolving landscape of pharmaceutical manufacturing, the integration of hybrid paper-electronic documentation systems has become increasingly prevalent. However, this…

How to Prevent Electronic Raw Data Paper Summary in Hybrid Paper–Electronic Systems

Preventing Issues with Electronic Raw Data Summary in Hybrid Paper–Electronic Systems As the pharmaceutical industry makes strides towards a more integrated digital environment, hybrid systems that combine paper-based and electronic…

Good Documentation Practices for Stability Study Records

Effective Strategies for Ensuring Compliance with Good Documentation Practices in Stability Studies In the pharmaceutical industry, the integrity and accuracy of documentation are paramount for meeting regulatory requirements and ensuring…